col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


33 Results       Page 1

 [1] 
Future Medicine: Immunotherapy
  original article Date Title Authors   All Authors
1 [GO] 2023―Jul―11 An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, Andrea S Fung, Pierre-Olivier Gaudreau
2 [GO] 2023―Jan―11 Comparing Bacillus Calmette-Guérin (BCG) strains in convalescent COVID-19 patients Mehrsa Jalalizadeh, Cristiane F Giacomelli, Patricia AF Leme, Keini Buosi, Luciana SB Dal Col, Franciele AV Dionato, et al. (+4)
3 [GO] 2022―Jul―27 Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma Mikhail Razumikhin, Tatiana Smolyanova, Alevtina Nikolaeva, Ekaterina Orlova, Aleksandr Ivanov, Olga Belyakova, et al. (+9)
4 [GO] 2022―Jul―20 Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19 Ragul Manoharan, Rajshekhar A Kore, Jawahar L Mehta
5 [GO] 2022―Jul―19 Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report Amalia Anastasopoulou, Aikaterini Gkoufa, Panagiotis Diamantopoulos, Spyridon Kazanas, Irene Eliadi, Michael Samarkos, Helen Gogas
6 [GO] 2022―Jul―05 Effectiveness of COVID-19 vaccines against Omicron variant Daniel Melo de Oliveira Campos, Maria Karolaynne da Silva, Claudio Bruno Silva de Oliveira, Umberto Laino Fulco, Jonas Ivan Nobre Oliveira
7 [GO] 2022―Jul―05 Reply to the letter ‘Effectiveness of COVID-19 vaccines against Omicron variant’ Vivek P Chavda, Shailvi Soni, Riddhi Prajapati, Murali M Yallapu, Vasso Apostolopoulos
8 [GO] 2022―Jun―13 Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report Angioletta Lasagna, Marco Vincenzo Lenti, Irene Cassaniti, Paolo Sacchi
9 [GO] 2022―Mar―21 Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment Henrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez, Anselmo A Abdo Cuza, Yamilka Hernández Sánchez, Aylin Granado Rodríguez, et al. (+15)
10 [GO] 2022―Feb―21 A global picture: therapeutic perspectives for COVID-19 Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu, Vasso Apostolopoulos
11 [GO] 2021―Nov―22 Nimotuzumab for COVID-19: case series Anselmo A Abdo Cuza, Jonathan Pi Ávila, Rafael Machado Martínez, José Jordán González, Guillermo Pérez Aspuro, Juan A Gutiérrez Martínez, et al. (+4)
12 [GO] 2021―Nov―08 The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't Alexandre E Malek, Paulette Pinargote Cornejo, Nour Daoud, Mohammad Alam
13 [GO] 2021―Sep―29 Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research Angioletta Lasagna, Marta Muzzana, Paolo Pedrazzoli
14 [GO] 2021―Aug―25 Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis Wenwei Qian, Ying Ye, Lugen Zuo, Ting Song, Qing Xu, Yinghong Wang, et al. (+2)
15 [GO] 2021―Jun―11 Appropriate use of antimicrobial therapy for COVID-19 co-infection Chih-Cheng Lai, Wen-Liang Yu
16 [GO] 2021―Apr―28 Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i) Marcelo Maia Pinheiro, Andrea Fabbri, Marco Infante
17 [GO] 2021―Feb―09 Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma Shaukat Ali, Syed M Uddin, Ayesha Ali, Fatima Anjum, Rashid Ali, Elisha Shalim, et al. (+7)
18 [GO] 2021―Jan―05 An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Jorge Alain Caballero, et al. (+11)
19 [GO] 2020―Dec―14 Immunity to glycan α-Gal and possibilities for the control of COVID-19 José de la Fuente, Christian Gortázar, Alejandro Cabezas-Cruz
20 [GO] 2020―Sep―22 COVID-19 and the newly rediscovered multidisciplinarity Melissa Bersanelli
21 [GO] 2020―Sep―16 Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy Melissa Bersanelli, Teresa Zielli, Fabiana Perrone, Chiara Casartelli, Fabiana Pratticò, Elena Rapacchi, et al. (+9)
22 [GO] 2020―Sep―09 COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy Cesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, Guilherme Harada, Pedro Paulo Marino Rodrigues Ayres, Daniela Bulhões Vieira Nunes, et al. (+2)
23 [GO] 2020―Sep―09 Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins José María Díez, Carolina Romero, Júlia Vergara-Alert, Melissa Belló-Perez, Jordi Rodon, José Manuel Honrubia, et al. (+4)
24 [GO] 2020―Jul―17 Obesity, COVID-19 and immunotherapy: the complex relationship! Carmine Finelli
25 [GO] 2020―Jul―15 Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients Juan David Cala-García, Juan David Sierra-Bretón, Jorge Eduardo Cavelier-Baiz, Álvaro A Faccini-Martínez, Carlos Eduardo Pérez-Díaz
26 [GO] 2020―Jul―09 How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology Ting Yi Jessica Chang, Janet E Pope
27 [GO] 2020―Jun―29 Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19 Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Alba Ariela Brandes
28 [GO] 2020―Jun―17 Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019 Megan Melody, Jared Nelson, Jacquelyn Hastings, Joshua Propst, Michael Smerina, Julio Mendez, Pramod Guru
29 [GO] 2020―Jun―03 Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors Patrizia Vici, Laura Pizzuti, Eriseld Krasniqi, Andrea Botticelli, Gennaro Ciliberto, Maddalena Barba
30 [GO] 2020―May―13 Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens José-María Díez, Carolina Romero, Rodrigo Gajardo
31 [GO] 2020―Apr―30 COVID-19: the use of immunotherapy in metastatic lung cancer Alexander P Davis, Michael Boyer, Jenny H Lee, Steven C Kao
32 [GO] 2020―Apr―15 Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection? Joseph Kattan, Clarisse Kattan, Tarek Assi
33 [GO] 2020―Mar―26 Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors Melissa Bersanelli
 [1] 

33 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec